DJIA 17,719.00 33.27 0.19%
NASDAQ 4,701.87 26.16 0.56%
S&P 500 2,052.75 4.03 0.20%
market minute promo

6.57 0.43 (7.00%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

ARIA $6.57 7.00%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $6.12
Previous Close $6.14
Daily Range $6.09 - $6.60
52-Week Range $2.53 - $9.83
Market Cap $1.2B
P/E Ratio -4.95
Dividend (Yield) $0.00 (0.0%)
Volume 8,486,409
Average Daily Volume 5,960,809
Current FY EPS -$1.09

Sector

Healthcare

Industry

Drugs

Ariad Pharmaceuticals, Inc. (ARIA) Description

The Company is engaged in the discovery and development of breakthrough medicines to treat cancers by regulating cell signaling with small molecules. Website: http://www.ariad.com/

News & Commentary Rss Feed

Why Ariad Pharmaceuticals, Inc. Stock Catapulted Higher

Ariad Pharmaceuticals stock is among today's top gainers after the Food and Drug Administration divvies a prized designation one of Ariad's pipeline products.

'Mad Money' Lightning Round: A Group to Avoid

Credit Suisse Expects New Pricing To Boost Sales For Ariad Pharmaceuticals

Ariad Pharmaceuticals' (ARIA) CEO Harvey Berger on Q3 2014 Results - Earnings Call Transcript

Sector Update: Health Care

Sector Update: Health Stocks Generally Higher Pre-Bell

ARIAD Pharmaceuticals (ARIA) Q3 2014 Results - Earnings Call Webcast

Earnings Scheduled For November 5, 2014

Will ARIAD (ARIA) Miss This Earnings Season? - Analyst Blog

Sector Update: Health Stocks Higher Pre-Bell

Sector Update: Health Care

See More ARIA News...

ARIA's Top Competitors

ARIA $6.57 (7.00%)
Current stock: ARIA
AMGN $162.68 (0.02%)
Current stock: AMGN
GILD $100.59 (-1.71%)
Current stock: GILD
BIIB $299.10 (-1.49%)
Current stock: BIIB